Stemcell specialists are latest addition to Cambridge life sciences cluster

« Back to Industry News

21/02/2017

The latest addition to the Cambridge life sciences cluster is a firm that provides reagents and tools to support researchers.

Stemcell Technologies has opened offices and a lab at Cambridge Research Park.

Founded in Canada by Dr Allen Eaves, the company supplies specialised reagents and tools that support research on cancer and other diseases, as well as cell therapy and regenerative medicine globally.

The firm, which has customers across Europe, is consolidating existing UK staff in the new office, which will eventually house a substantial R&D group, as well as sales, marketing and other support staff. A major focus of the new facility will be a state-of-the-art education and teaching lab, offering standard and customised training courses and workshops.

Dr Eaves said: “Stemcell is committed to driving the advancement of science by offering the highest quality products and services to support scientists with their research. We are thrilled to be officially opening our new Cambridge office, including our Research and Development labs and Education Centre.

"Steamcell has seen fantastic growth, and this facility will take us to the next level in supporting medical sciences research globally, as well as open our doors to the incredible biomedical expertise in the UK and Europe.”


Click here to view the related article.

« Back to Industry News